Related Experiment Video
Updated: Mar 11, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Presymptomatic diagnosis of Fabry's disease: a case report
Rasmus Bo Hasselbalch1, Per Lav Madsen2, Henning Bundgaard3
1Department of Cardiology, Copenhagen University Hospital - Herlev-Gentofte Hospital, Herlev Ringvej 75, Herlev, 2730, Denmark. r.hasselbalch@gmail.com.
Insights
Fabry disease, a genetic disorder affecting the alpha-galactosidase A enzyme, can mimic hypertrophic cardiomyopathy. Early diagnosis through cascade screening is crucial for affected families.
Area of Science:
- Genetics
- Cardiology
- Rare Diseases
Background:
- Fabry disease is an X-linked genetic disorder caused by deficient alpha-galactosidase A enzyme activity.
- Cardiac involvement, mimicking hypertrophic cardiomyopathy, is a significant clinical manifestation.
- Early symptoms in males include neuropathic pain and GI issues, progressing to cardiac, renal, and CNS effects.
Observation:
- A case of Fabry disease was diagnosed in a daughter of an 81-year-old woman with late-onset cardiac disease.
- The proband presented with cardiac conduction disease and heart failure.
Findings:
- This case highlights the importance of considering Fabry disease in elderly patients with cardiac hypertrophy.
- Cascade screening of relatives is essential for identifying affected individuals, including asymptomatic female carriers.
Implications:
- Accurate diagnosis of Fabry disease is critical for timely enzyme replacement therapy and management.
- Identifying Fabry disease in elderly patients prompts cascade screening, potentially revealing the disorder in younger family members.
- Physicians should consider Fabry disease as a differential diagnosis in inherited cardiomyopathies, regardless of patient age.
Background:
Fabry's disease is a rare X-linked genetic disorder characterized by reduced levels of the α-galactosidase A enzyme. It may present with a cardiac phenotype resembling hypertrophic cardiomyopathy. However, as a specific enzyme replacement therapy is available, it remains an important differential diagnoses in patients presenting with cardiac hypertrophy. In boys, onset has been reported in early childhood with complaints initially comprising neuropathic pain, reduced sweat production, and gastrointestinal symptoms. Later the cardiac, renal, and central nervous systems may become affected. Female mutation carriers may remain asymptomatic or present at a later age with varying symptoms and clinical manifestations due to random inactivation of the X chromosome in different organs.
Case Presentation:
Here we present a case of Fabry's disease diagnosed in the daughter of an elderly, Caucasian woman (81 years old) with late-onset cardiac conduction disease and heart failure. We discuss the implications of cascade screening relatives of elderly probands.
Conclusions:
Irrespective of the patient's age, physicians must be on the lookout for phenocopies when identifying patients with possibly inheritable cardiomyopathies. The specific - precise - diagnosis may be crucial for the patient as well as the relatives.
More Related Videos
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

